980 results on '"Farde, L"'
Search Results
2. Disease activity in rheumatoid arthritis is inversely related to cerebral TSPO binding assessed by [11C]PBR28 positron emission tomography
3. Altered Serotonin 1B Receptor Binding After Escitalopram for Depression Is Correlated With Treatment Effect.
4. Mapping the distribution of serotonin transporter in the human brainstem with high-resolution PET: Validation using postmortem autoradiography data
5. Lower levels of the glial cell marker TSPO in drug-naive first-episode psychosis patients as measured using PET and [11C]PBR28
6. Glutamate 5 receptor availability differences in twins discordant for autism and controls, do shared genetics matter
7. Contribution of non-genetic factors to dopamine and serotonin receptor availability in the adult human brain
8. PET for Drug Development
9. Test–retest reproducibility of [11C]PBR28 binding to TSPO in healthy control subjects
10. PET Studies in the Early Clinical Development of a New Antipsychotic
11. PET-Studien zur Dopaminrezeptorbindung bei neuroleptisch behandelten Patienten
12. Xanomeline, A Specific M1 Agonist: Early Clinical Studies
13. PET Examination of Central D2 Dopamine Receptor Occupancy in Relation to Extrapyramidal Syndromes in Patients Being Treated with Neuroleptic Drugs
14. Age-related reduction in dopamine D1 receptors in the human brain: from late childhood to adulthood, a positron emission tomography study
15. Positron Emission Tomography in Schizophrenia
16. Die Bedeutung der D1- und D2-Dopaminrezeptor-Blockade für die antipsychotische Wirkung von Neuroleptika. Eine PET-Studie an schizophrenen Patienten
17. The Future of Psychopharmacology and Positron Emission Tomography
18. Age-related loss of olfactory sensitivity: Association to dopamine transporter binding in putamen
19. Effect of the myeloperoxidase inhibitor AZD3241 on translocator protein binding in brain - A positron emission tomography study in patients with Parkinsonʼs disease: 662
20. Examination of the dopamine transporter in striatum and substantia nigra in Parkinsonʼs disease with [18F]FE-PE2I and high-resolution PET: 195
21. P76.72 A PET and MRI Study Exploring Osimertinib Brain Exposure and Efficacy in EGFRm NSCLC CNS Metastases
22. Transcription factor AP-2β genotype, striatal dopamine D2 receptor density and cerebrospinal fluid monoamine metabolite concentrations in humans
23. Autoradiographic Evaluation of [11 C] Vinpocetine Binding in the Human Postmortem Brain
24. Z-IQNP: a potential radioligand for SPECT imaging of muscarinic acetylcholine receptors in Alzheimer’s disease
25. High 5HT2A receptor occupancy in M100907-treated schizophrenic patients
26. Polymorphisms in the dopamine D2 receptor gene and their relationships to striatal dopamine receptor density of healthy volunteers
27. Brain Age Prediction Reveals Aberrant Brain White Matter in Schizophrenia and Bipolar Disorder: A Multisample Diffusion Tensor Imaging Study
28. Changes in Cortical Dopamine D1 Receptor Binding Associated with Cognitive Training
29. A PET-study of [11C]FLB 457 binding to extrastriatal D2-dopamine receptors in healthy subjects and antipsychotic drug-treated patients
30. PET-characterization of [carbonyl-11C]WAY-100635 binding to 5-HT1A receptors in the primate brain
31. Quantitative analysis of dopamine D2 receptor binding in human brain using PET with an agonist radioligand [11C]MNPA: Poster Presentation No.: P074
32. Quantitative analyses of [11C]AZ10419369 binding to 5-HT1B receptors in the human brain: Poster Presentation No.: P045
33. Radiosynthesis of [11C]MNPA from the precursor (R)-(−)-2-hydroxy-10,11-acetonide-NPA and a preliminary test–retest PET analysis in monkey brain: Poster Presentation No.: P043
34. COMT inhibition prevents the formation of lipophilic radiometabolites of catechols, — An example with (S)-[11C]N-methyl-NNC 01-0259: Poster Presentation No.: P032
35. Advancement in PET quantification using 3D-OP-OSEM PSF reconstruction with the HRRT: Poster Presentation No.: P026
36. Automated system for parametric image analysis in neuroreceptor binding studies with PET: Poster Presentation No.: P019
37. Dopamine D2/3 receptor occupancy of apomorphine in the non-human primate brain does not support the existence of two affinity states in vivo: Oral Presentation No.: O25
38. [11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET); Characterization in cynomolgus monkey brain: Oral Presentation No.: O6
39. Common brain disorders are associated with heritable patterns of apparent aging of the brain
40. Development of radioligands for the dopamine transporter
41. Evaluation of SCH 39166 as PET ligand for central D1 dopamine receptor binding and occupancy in man
42. Lack of apparent antipsychotic effect of the D1-dopamine recepotr antagonist SCH39166 in acutely ill schizophrenic patients
43. Oral administration of NNC 756 — a placebo controlled PET study of D1-dopamine receptor occupancy and pharmacodynamics in man
44. Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion: A PET study in nonhuman primate brain using (S,S)-[18F]FMeNER-D2
45. An open clinical and biochemical study of ritanserin in acute patients with schizophrenia
46. The genetic architecture of human brainstem structures and their involvement in common brain disorders
47. Interaction study between remoxipride and biperiden
48. PET analysis of alcohol interaction with the brain disposition of [11C]flumazenil
49. NCQ 298, a new selective iodinated salicylamide ligand for the labelling of dopamine D2 receptors
50. On the pathopysiology of schizophrenia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.